A-Labs Capital IV Corp.
ALCCP.V
TSX
| 03/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 185.11% | -38.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 185.11% | -38.96% | |||
| Operating Income | -185.11% | 38.96% | |||
| Income Before Tax | -185.11% | 38.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -185.11% | 38.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -185.11% | 38.96% | |||
| EBIT | -185.11% | 38.96% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -191.30% | 39.47% | |||
| Normalized Basic EPS | -180.00% | 37.50% | |||
| EPS Diluted | -191.30% | 39.47% | |||
| Normalized Diluted EPS | -180.00% | 37.50% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
